BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical trial for CERAMENT|G in 2Q16.
BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical...
BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical trial for CERAMENT|G in 2Q16.
Copy to clipboard 
